Literature DB >> 23032975

Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells.

Shin-ichiro Ohno1, Masakatsu Takanashi, Katsuko Sudo, Shinobu Ueda, Akio Ishikawa, Nagahisa Matsuyama, Koji Fujita, Takayuki Mizutani, Tadaaki Ohgi, Takahiro Ochiya, Noriko Gotoh, Masahiko Kuroda.   

Abstract

Despite the therapeutic potential of nucleic acid drugs, their clinical application has been limited in part by a lack of appropriate delivery systems. Exosomes or microvesicles are small endosomally derived vesicles that are secreted by a variety of cell types and tissues. Here, we show that exosomes can efficiently deliver microRNA (miRNA) to epidermal growth factor receptor (EGFR)-expressing breast cancer cells. Targeting was achieved by engineering the donor cells to express the transmembrane domain of platelet-derived growth factor receptor fused to the GE11 peptide. Intravenously injected exosomes delivered let-7a miRNA to EGFR-expressing xenograft breast cancer tissue in RAG2(-/-) mice. Our results suggest that exosomes can be used therapeutically to target EGFR-expressing cancerous tissues with nucleic acid drugs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23032975      PMCID: PMC3538304          DOI: 10.1038/mt.2012.180

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  21 in total

Review 1.  Accelerated blood clearance (ABC) phenomenon upon repeated injection of PEGylated liposomes.

Authors:  Tatsuhiro Ishida; Hiroshi Kiwada
Journal:  Int J Pharm       Date:  2007-11-09       Impact factor: 5.875

Review 2.  Cell to cell signalling via exosomes through esRNA.

Authors:  Jan Lotvall; Hadi Valadi
Journal:  Cell Adh Migr       Date:  2007-07-04       Impact factor: 3.405

3.  Disconnecting the yin and yang relation of epidermal growth factor receptor (EGFR)-mediated delivery: a fully synthetic, EGFR-targeted gene transfer system avoiding receptor activation.

Authors:  A Schäfer; A Pahnke; D Schaffert; W M van Weerden; C M A de Ridder; W Rödl; A Vetter; C Spitzweg; R Kraaij; E Wagner; Manfred Ogris
Journal:  Hum Gene Ther       Date:  2011-08-10       Impact factor: 5.695

4.  The tumor suppressor microRNA let-7 represses the HMGA2 oncogene.

Authors:  Yong Sun Lee; Anindya Dutta
Journal:  Genes Dev       Date:  2007-04-16       Impact factor: 11.361

5.  Microvesicle-mediated RNA molecule delivery system using monocytes/macrophages.

Authors:  Yukihiro Akao; Akio Iio; Tomohiro Itoh; Shunsuke Noguchi; Yuko Itoh; Yoshinori Ohtsuki; Tomoki Naoe
Journal:  Mol Ther       Date:  2010-11-23       Impact factor: 11.454

6.  Identification and characterization of a novel peptide ligand of epidermal growth factor receptor for targeted delivery of therapeutics.

Authors:  Zonghai Li; Ruijiao Zhao; Xianghua Wu; Ye Sun; Ming Yao; Jinjun Li; Yuhong Xu; Jianren Gu
Journal:  FASEB J       Date:  2005-12       Impact factor: 5.191

7.  Epidermal growth factor receptor-targeted (131)I-therapy of liver cancer following systemic delivery of the sodium iodide symporter gene.

Authors:  Kathrin Klutz; David Schaffert; Michael J Willhauck; Geoffrey K Grünwald; Rudolf Haase; Nathalie Wunderlich; Christian Zach; Franz J Gildehaus; Reingard Senekowitsch-Schmidtke; Burkhard Göke; Ernst Wagner; Manfred Ogris; Christine Spitzweg
Journal:  Mol Ther       Date:  2011-01-18       Impact factor: 11.454

8.  MicroRNA let-7: an emerging next-generation cancer therapeutic.

Authors:  D Barh; R Malhotra; B Ravi; P Sindhurani
Journal:  Curr Oncol       Date:  2010-02       Impact factor: 3.677

9.  Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival.

Authors:  Junichi Takamizawa; Hiroyuki Konishi; Kiyoshi Yanagisawa; Shuta Tomida; Hirotaka Osada; Hideki Endoh; Tomoko Harano; Yasushi Yatabe; Masato Nagino; Yuji Nimura; Tetsuya Mitsudomi; Takashi Takahashi
Journal:  Cancer Res       Date:  2004-06-01       Impact factor: 12.701

10.  The let-7 microRNA represses cell proliferation pathways in human cells.

Authors:  Charles D Johnson; Aurora Esquela-Kerscher; Giovanni Stefani; Mike Byrom; Kevin Kelnar; Dmitriy Ovcharenko; Mike Wilson; Xiaowei Wang; Jeffrey Shelton; Jaclyn Shingara; Lena Chin; David Brown; Frank J Slack
Journal:  Cancer Res       Date:  2007-08-15       Impact factor: 12.701

View more
  514 in total

Review 1.  Using exosomes, naturally-equipped nanocarriers, for drug delivery.

Authors:  Elena V Batrakova; Myung Soo Kim
Journal:  J Control Release       Date:  2015-08-01       Impact factor: 9.776

Review 2.  Extracellular vesicles in breast cancer drug resistance and their clinical application.

Authors:  Shentong Yu; Yifang Wei; Yuqiao Xu; Yuan Zhang; Jipeng Li; Jian Zhang
Journal:  Tumour Biol       Date:  2016-01-21

3.  Evaluation of electroporation-induced adverse effects on adipose-derived stem cell exosomes.

Authors:  Kasper Bendix Johnsen; Johann Mar Gudbergsson; Martin Najbjerg Skov; Gunna Christiansen; Leonid Gurevich; Torben Moos; Meg Duroux
Journal:  Cytotechnology       Date:  2016-02-08       Impact factor: 2.058

Review 4.  MicroRNAs as therapeutic targets in human cancers.

Authors:  Maitri Y Shah; George A Calin
Journal:  Wiley Interdiscip Rev RNA       Date:  2014-03-28       Impact factor: 9.957

Review 5.  Synthetic nucleic acids delivered by exosomes: a potential therapeutic for generelated metabolic brain diseases.

Authors:  Rutao Liu; Jing Liu; Xiaofei Ji; Yang Liu
Journal:  Metab Brain Dis       Date:  2013-12       Impact factor: 3.584

6.  Aptamer-Conjugated Extracellular Nanovesicles for Targeted Drug Delivery.

Authors:  Yuan Wan; Lixue Wang; Chuandong Zhu; Qin Zheng; Guoxiang Wang; Jinlong Tong; Yuan Fang; Yiqiu Xia; Gong Cheng; Xia He; Si-Yang Zheng
Journal:  Cancer Res       Date:  2017-12-07       Impact factor: 12.701

Review 7.  Exosomes: Definition, Role in Tumor Development and Clinical Implications.

Authors:  Alberto Carretero-González; Irene Otero; Lucía Carril-Ajuria; Guillermo de Velasco; Luis Manso
Journal:  Cancer Microenviron       Date:  2018-05-03

8.  MicroRNA expression signatures and their correlation with clinicopathological features in glioblastoma multiforme.

Authors:  Michael Henriksen; Kasper Bendix Johnsen; Pia Olesen; Linda Pilgaard; Meg Duroux
Journal:  Neuromolecular Med       Date:  2014-05-10       Impact factor: 3.843

9.  Differential in vivo biodistribution of 131I-labeled exosomes from diverse cellular origins and its implication for theranostic application.

Authors:  Mohammad H Rashid; Thaiz F Borin; Roxan Ara; Kartik Angara; Jingwen Cai; Bhagelu R Achyut; Yutao Liu; Ali S Arbab
Journal:  Nanomedicine       Date:  2019-08-01       Impact factor: 5.307

10.  Efficient production and enhanced tumor delivery of engineered extracellular vesicles.

Authors:  Dionysios C Watson; Defne Bayik; Avinash Srivatsan; Cristina Bergamaschi; Antonio Valentin; Gang Niu; Jenifer Bear; Mitchell Monninger; Mei Sun; Aizea Morales-Kastresana; Jennifer C Jones; Barbara K Felber; Xiaoyuan Chen; Ihsan Gursel; George N Pavlakis
Journal:  Biomaterials       Date:  2016-07-06       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.